Financial Life Planners Has $122,000 Holdings in Axon Enterprise, Inc $AXON

Financial Life Planners decreased its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 93.9% in the 1st quarter, HoldingsChannel reports. The fund owned 286 shares of the biotechnology company’s stock after selling 4,391 shares during the period. Financial Life Planners’ holdings in Axon Enterprise were worth $122,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Rockefeller Capital Management L.P. lifted its stake in shares of Axon Enterprise by 53.2% in the fourth quarter. Rockefeller Capital Management L.P. now owns 11,518 shares of the biotechnology company’s stock valued at $6,542,000 after buying an additional 4,002 shares in the last quarter. Legal & General Group Plc grew its holdings in shares of Axon Enterprise by 1.3% during the fourth quarter. Legal & General Group Plc now owns 426,533 shares of the biotechnology company’s stock valued at $242,241,000 after buying an additional 5,419 shares during the last quarter. Eurizon Capital SGR S.p.A. bought a new stake in shares of Axon Enterprise during the fourth quarter worth about $13,116,000. Wealth Enhancement Advisory Services LLC increased its position in shares of Axon Enterprise by 93.1% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 23,365 shares of the biotechnology company’s stock worth $13,270,000 after acquiring an additional 11,262 shares in the last quarter. Finally, Teamwork Financial Advisors LLC raised its holdings in shares of Axon Enterprise by 40.5% in the 4th quarter. Teamwork Financial Advisors LLC now owns 25,352 shares of the biotechnology company’s stock worth $14,398,000 after acquiring an additional 7,307 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts recently weighed in on AXON shares. Citizens Jmp reaffirmed a “market outperform” rating and issued a $700.00 price target on shares of Axon Enterprise in a research report on Thursday, June 25th. Morgan Stanley set a $600.00 price objective on Axon Enterprise in a research note on Thursday, May 7th. The Goldman Sachs Group set a $535.00 target price on Axon Enterprise in a report on Thursday, May 7th. Barclays cut their target price on Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating on the stock in a research report on Friday, May 8th. Finally, JPMorgan Chase & Co. upped their price target on Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $712.75.

Axon Enterprise News Summary

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: News that President Trump bought Axon shares and that ICE later sought a large Taser contract has fueled speculation about future government demand for Axon’s products. Trump bought as much as $5 million in Axon stock before ICE sought $220 million Taser deal
• Positive Sentiment: Axon’s recent operating momentum is also supporting the stock, including first-quarter revenue growth of 34% year over year and management’s raised 2026 growth outlook. Axon Enterprise jumps as investors react to disclosure-linked contract narrative and strong operating momentum
• Neutral Sentiment: Analysts remain generally constructive, with Northland Securities reiterating a buy rating and several recent price targets clustering well above prior trading levels. Northland Securities Reaffirms Their Buy Rating on Axon Enterprise (AXON)
• Neutral Sentiment: One headline also noted ongoing debate about valuation and whether the stock’s recent rebound is being driven more by momentum and political headlines than fundamentals. Axon Enterprise (AXON) Stock After Recent Volatility Is The Current Price Justified
• Negative Sentiment: The Trump-Axon-ICE connection has also raised ethics and conflict-of-interest questions, which could create political and reputational risk around government contracting. Axon Enterprise (AXON) Stock Drew Ethics Questions After Trump Bought $5 Million In Shares
• Negative Sentiment: Insider selling remains a headwind for sentiment, with the CEO recently selling shares under a pre-arranged trading plan and no insider purchases reported in the last six months. Axon Enterprise Stock Performance

Axon Enterprise Trading Up 9.8%

NASDAQ:AXON opened at $560.61 on Wednesday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27. The firm has a market cap of $45.19 billion, a price-to-earnings ratio of 225.14, a price-to-earnings-growth ratio of 10.42 and a beta of 1.45. Axon Enterprise, Inc has a 52 week low of $339.01 and a 52 week high of $885.91. The firm has a 50-day moving average price of $426.15 and a two-hundred day moving average price of $481.27.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The firm had revenue of $807.35 million for the quarter, compared to the consensus estimate of $778.90 million. During the same quarter in the previous year, the business earned $1.47 EPS. The company’s revenue was up 33.7% compared to the same quarter last year. On average, equities analysts expect that Axon Enterprise, Inc will post 1.63 earnings per share for the current fiscal year.

Insider Activity at Axon Enterprise

In related news, President Joshua Isner sold 13,000 shares of Axon Enterprise stock in a transaction on Friday, June 5th. The stock was sold at an average price of $488.45, for a total transaction of $6,349,850.00. Following the sale, the president directly owned 169,125 shares in the company, valued at approximately $82,609,106.25. This trade represents a 7.14% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Elizabeth Reid Coughlin sold 1,554 shares of the business’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $485.00, for a total value of $753,690.00. Following the completion of the transaction, the insider directly owned 34,024 shares in the company, valued at approximately $16,501,640. This represents a 4.37% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 48,989 shares of company stock valued at $24,090,083 in the last ninety days. Insiders own 4.20% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.